Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avantis U.S. Equity ETF (NY:AVUS)

107.61 -0.39 (-0.36%)
Official Closing Price Updated: 8:00 PM EDT, Sep 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Avantis U.S. Equity ETF

< Previous 1 2 Next >
GE Vernova To Sell Proficy Software Unit To TPG For $600M
Via Stocktwits
Delta CEO Says Consumer Confidence Recovers From ‘Big Impact’ Earlier This Year: Report
Via Stocktwits
Ford Draws Retail Investor Concerns After It Recalls Nearly 1.5M Vehicles In US Over Rear View Camera Display Issues
Via Stocktwits
Topics Product Recall
Regeneron Says Experimental Therapy Reduced Symptoms Of Cat, Birch Allergies In Late-Stage Trials
Via Stocktwits
Halliburton Reduces Workforce As Costs Rise Amid Lower Oil Prices: Report
Via Stocktwits
This Pharma Stock Soared 36% Today And Drew Price Target Hikes From Wall Street – More Details Inside
Via Stocktwits
Lucid Stock Gets A Price Target Cut From Stifel As It Gears Up For A Reverse Stock Split: Retail Sees 50% Dive Post Split
Via Stocktwits
Ford Issues Nearly 356,000 Vehicles Recall In U.S., But Retail Investors Spot Emerging Catalysts
The U.S. auto safety regulator said that an instrument panel display that does not show critical information, such as warning lights or vehicle speed, can increase the risk of a crash. 
Via Stocktwits
Topics Electric Vehicles
Regeneron Stock Rallies After Therapy For Autoimmune Disease Meets Late-Stage Trial Goals: Retail Thinks Stock Might Hit An All-Time Low Soon
Via Stocktwits
Vanda Pharma Stock Rockets 9% After Federal Appeals Court Sets Aside FDA Action: Retail Expects Stock To Cross $5-Mark
Via Stocktwits
Medtronic Appoints New Directors After Elliott Becomes Major Investor: Company Hikes FY26 Guidance After Q1 Beat
Elliott Partner Marc Steinberg stated that the decision to become one of the largest investors in Medtronic was driven by the conviction that the company is entering a new chapter of value creation. 
Via Stocktwits
Lyft Has A ‘Steady Path Forward’ According To UBS: Retail Thinks Stock Is Undervalued
Via Stocktwits
This Aviation Stock Has Doubled In 2025, Surged Over 200% In 12 Months, And Is Trending On Friday – Do You Own It?
Via Stocktwits
This Stock Has Tumbled 50% In One Year, Gets A Price Target Cut Today – But Retail Believes $400-450 Is A Good Entry Point
Truist, however, kept a ‘Buy’ rating on the shares. 
Via Stocktwits
Rivian Plans Shut Down Of Illinois Plant For Three Weeks, R2 Hopes Sparks Mixed Reactions Among Retail Investors
The R2 SUV is expected to be launched in the first half of 2026. 
Via Stocktwits
Cigna Stock Slides 8% On Thursday But Wells Fargo Analyst Is Surprised: Here’s What Happened
Via Stocktwits
Humana Stock Gains On Upbeat Earnings And Raised Guidance, Drawing Retail Praise And UnitedHealth Contrasts
Via Stocktwits
Revvity CEO Acknowledges Challenges In Immunodiagnostics Business In China: Retail Terms Stock Drop An ‘Overreaction’
Via Stocktwits
Centene Reports Unexpected Q2 Loss: But Retail Expects Stock To Close Higher
Via Stocktwits
Pfizer In Talks With Trump Administration Regarding Lower Drug Prices And Tariffs, Says CEO: Stock Rallies On Improved Full-Year Guidance, Upbeat Q2 Report
Via Stocktwits
Topics Government
BioCryst Eyes Strengthening Pipeline After Upbeat Q2 Earnings: Retail Thinks Fair Valuation For Stock Is Double The Current Level
CEO Jon Stonehouse stated during the company’s earnings call on Monday that the firm’s Netherton Syndrome and DME pipeline programs remain on track to have some data by the end of the year. 
Via Stocktwits
Topics Artificial Intelligence Earnings
Ford US Sales Rise 9.3% In July: Retail Gets Curious About August 11 Revelation
While hybrid vehicle and internal combustion engine vehicle sales rose 11.8% and 9.5%, respectively, last month, electric vehicle sales fell 0.2%. 
Via Stocktwits
Topics Earnings Electric Vehicles World Trade
CVS Health CFO Says Company Maintaining Prudent View On Medical Cost Trends Through Remainder Of Year
The firm now expects full-year adjusted earnings per share of $6.30 to $6.40, up from its previous guidance of $6.00 to $6.20. 
Via Stocktwits
Topics Artificial Intelligence Earnings Workforce
Retail Chatter On BMY Doubles In 24 Hours With Drug Failing To Meet Primary Goal: Here's What Investors Are Thinking
Via Stocktwits
Autoliv Draws Retail Cheer As CEO Says Company Recovered Significant Portion Of Tariff Costs From Customers In Q2
Via Stocktwits
Rivian CEO Transfers Portion Of Holdings In EV Maker To Ex-Wife As Part Of Divorce Settlement
Via Stocktwits
Lucid Signs Up Timothée Chalamet As Global Brand Ambassador: Retail Terms It A Desperate Cash-Draining Move
Chalamet will headline Lucid’s new marketing campaign for its Gravity SUV later this year. 
Via Stocktwits
Lucid Collaborates With 4 Critical Mineral Producers To Strengthen Supply Chain: Retail Deems It A ‘Comeback’
Lucid has joined forces with Alaska Energy Metals, Graphite One, Electric Metals, and RecycLiCo. 
Via Stocktwits
Topics Artificial Intelligence Supply Chain
Humana To Slash Red Tape Around Prior Authorization For Care Services By 2026: Retail Remains Optimistic
Humana CEO Jim Rechtin said that the current healthcare system is “too complex, frustrating, and difficult to navigate” while emphasising the need to “do better.” 
Via Stocktwits
Abbott Stock Slips On Disappointing Q3 Earnings Forecast: Retail Chatter Rises Over 200% In 24 Hours
Abbott’s sales of continuous glucose monitors were $1.9 billion in the second quarter, marking a growth of 21.4% on a reported basis, the company said. 
Via Stocktwits
Topics Artificial Intelligence
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.